Emergent Biosolutions (EBS) Gets Exclusive Rights to VaxInnate’s Flu Vaccine

Go back to Emergent Biosolutions (EBS) Gets Exclusive Rights to VaxInnate’s Flu Vaccine
EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) Delayed: 4.66 --0 (-0%)
Previous Close $4.66    52 Week High $44.38 
Open $4.66    52 Week Low $24.47 
Day High $4.66    P/E 233.00 
Day Low $4.66    EPS $0.02 
Volume 165